/
CBT
$90.36-$3.04 (-3.25%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.8B
52M shares
52-week range
$58.33 – $94.53
88% from low
Sector
MISCELLANEOUS CHEMICAL PRODUCTS
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$32.05
Cabot Corporation
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
www.cabotcorp.com- Employees
- 4,100
- IPO / List date
- Aug 23, 1968
- HQ
- BOSTON, MA
Held by traders on TradeandTell
No one on the platform currently holds CBT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 30,700 | $2.0M |
| Bridgewater Associatesas of 2026-03-31 | 27,354 | $2.1M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.02% ($1.82/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-29 | $0.4725 | 2026-06-12 |
| 2026-02-27 | $0.4500 | 2026-03-13 |
| 2025-11-28 | $0.4500 | 2025-12-12 |
| 2025-08-29 | $0.4500 | 2025-09-11 |
| 2025-05-30 | $0.4500 | 2025-06-13 |
| 2025-02-28 | $0.4300 | 2025-03-14 |
| 2024-11-29 | $0.4300 | 2024-12-13 |
| 2024-08-30 | $0.4300 | 2024-09-13 |
| 2024-05-31 | $0.4300 | 2024-06-14 |
| 2024-02-22 | $0.4000 | 2024-03-08 |
Recent trades on TradeandTell
No one on the platform has traded CBT yet.
